{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T13:30:25Z","timestamp":1762176625096},"reference-count":42,"publisher":"Baishideng Publishing Group Inc.","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJGE"],"published-print":{"date-parts":[[2012]]},"DOI":"10.4253\/wjge.v4.i11.506","type":"journal-article","created":{"date-parts":[[2012,11,27]],"date-time":"2012-11-27T01:11:15Z","timestamp":1353978675000},"page":"506","source":"Crossref","is-referenced-by-count":5,"title":["Losartan to prevent hyperenzymemia after endoscopic retrograde cholangiopan-creatography: A randomized clinical trial"],"prefix":"10.4253","volume":"4","author":[{"given":"Tomas Sj\u00f6berg","family":"Bexelius","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S1542-3565(04)00671-8"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0b013e31817f528f"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2008.10.039"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5107(04)02169-8"},{"key":"ref5","unstructured":"Freeman ML. Post-ERCP pancreatitis: patient and technique-related risk factors. JOP 2002;3:169-176."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2006.10.030"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-8-6"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/gut.52.12.1768"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5107(99)70387-1"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1009081"},{"key":"ref11","unstructured":"Kisli E, Baser M, Aydin M, Guler O. The role of octreotide versus placebo in the prevention of post-ERCP pancreatitis. Hepatogastroenterology 2007;54:250-253."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00959.x"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Thomopoulos KC, Pagoni NA, Vagenas KA, Margaritis VG, Theocharis GI, Nikolopoulou VN. Twenty-four hour prophylaxis with increased dosage of octreotide reduces the incidence of post-ERCP pancreatitis. Gastrointest Endosc 2006;64:726-731.","DOI":"10.1016\/j.gie.2006.03.934"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3109\/00365529509093278"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5107(75)73837-3"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199609263351302"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.07698.x"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-006-1986-8"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-7-6"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5107(77)73457-1"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2006.04085.x"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1067\/mge.2002.122616"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9270(99)00054-4"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1067\/mge.2003.307"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(03)00384-6"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.21172"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1067\/mge.2003.29"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/S1091-255X(01)80059-7"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(87)90437-2"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/S0303-7207(00)00275-6"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.regpep.2004.02.003"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/S1357-2725(03)00257-7"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.etp.2009.05.001"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.107.124891"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1159\/000225906"},{"key":"ref36","unstructured":"Dickstein K, Gottlieb S, Fleck E, Kostis J, Levine B, DeKock M, LeJemtel T. Hemodynamic and neurohumoral effects of the angiotensin II antagonist losartan in patients with heart failure. J Hypertens Suppl 1994;12:S31-S35."},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.88.4.1602"},{"key":"ref38","unstructured":"Gottlieb SS. Lakemedelsverkets foreskrifter och allmanna rad om klinisk provning av lakemedel for humant bruk Lakemedelsverket: Director General Gunnar Alvan; 2003;1-25."},{"key":"ref39","unstructured":"European Medical Agency. Guideline for Good Clinical Practice London: European Medical Agency; 2006;59."},{"key":"ref40","unstructured":"European Medical Agency. Guideline on missing data in confirmatory clinical trials London: European Medical Agency; 2009;13."},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1993.01420170122019"},{"key":"ref42","unstructured":"Brunicardi CAD, Billiar T, Dunn D, Hunter J, Matthews J, Pollock R. Schwartz's Principles of Surgery. 9th ed Pancreas: McGraw-Hill; 2009;."}],"container-title":["World Journal of Gastrointestinal Endoscopy"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,7,6]],"date-time":"2019-07-06T00:27:09Z","timestamp":1562372829000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1948-5190\/full\/v4\/i11\/506.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":42,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.4253\/wjge.v4.i11.506","relation":{},"ISSN":["1948-5190"],"issn-type":[{"value":"1948-5190","type":"print"}],"subject":[],"published":{"date-parts":[[2012]]}}}